World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
37315
World Ranking
7395
National Ranking
422

Thomas Klingebiel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas Klingebiel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 694 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Thomas Klingebiel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas Klingebiel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Thomas Klingebiel is a researcher affiliated with Goethe University Frankfurt in Germany. Their work primarily falls within the field of Medicine, with particular emphasis on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Hematology, and Pediatrics, Perinatology and Child Health.

The scientist has contributed extensively to topics including:

  • Sarcoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Tumors and Oncological Cases
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Hematopoietic Stem Cell Transplantation

Notable recent research papers authored or co-authored by Thomas Klingebiel include:

  • "Sarcoma classification by DNA methylation profiling" (2021), published in Nature Communications
  • "Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia" (2021), published in JAMA
  • "Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study" (2020), published in Bone Marrow Transplantation
  • "Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR" (2020), published in Annals of Oncology
  • "Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)" (2023), published in Journal of Clinical Immunology

Their frequent collaborators include:

  • Peter Bader
  • Ewa Kościelniak
  • Monika Sparber-Sauer
  • Gustaf Ljungman
  • Bernd Gruhn

Thomas Klingebiel's work appears regularly in journals such as:

  • Pediatric Blood & Cancer
  • Monatsschrift Kinderheilkunde
  • Bone Marrow Transplantation
  • Cancers
  • Klinische Pädiatrie

Best Publications

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95

    Anja Möricke;Alfred Reiter;Martin Zimmermann;Helmut Gadner

  • Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000

    A Möricke;M Zimmermann;A Reiter;G Henze

  • Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)

    Beate Kempf-Bielack;Stefan S. Bielack;Heribert Jürgens;Detlev Branscheid

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

    Alfred Reiter;Martin Schrappe;Markus Tiemann;Wolf-Dieter Ludwig

  • Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

    Einsele H;Ehninger G;Hebart H;Wittkowski Km

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.

    Frank Berthold;Joachim Boos;Stefan Burdach;Rudolf Erttmann

  • Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

    Peter Bader;Hermann Kreyenberg;Günter H.R. Henze;Cornelia Eckert

  • The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95

    Wilhelm Woessmann;Kathrin Seidemann;Georg Mann;Martin Zimmermann

  • Megadose transplantation of purified peripheral blood CD34 + progenitor cells from HLA-mismatched parental donors in children

    R Handgretinger;T Klingebiel;P Lang;P Lang;M Schumm;M Schumm

  • Breast carcinoma during pregnancy. International recommendations from an expert meeting.

    Sibylle Loibl;Gunter von Minckwitz;Karin Gwyn;Paul Ellis

  • Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90

    Gesche Tallen;Richard Ratei;Georg Mann;Gertjan Kaspers

  • Long-Term Outcome in Children With Relapsed ALL by Risk-Stratified Salvage Therapy: Results of Trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 87

    Hagen Graf Einsiedel;Arend von Stackelberg;Reinhard Hartmann;Rüdiger Fengler

  • Sarcoma classification by DNA methylation profiling

    Christian Koelsche;Christian Koelsche;Daniel Schrimpf;Daniel Schrimpf;Damian Stichel;Martin Sill

  • A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

    R. Handgretinger;K. Anderson;P. Lang;R. Dopfer

  • Results of Treatment for Soft Tissue Sarcoma in Childhood and Adolescence: A Final Report of the German Cooperative Soft Tissue Sarcoma Study CWS-86

    Ewa Koscielniak;Dieter Harms;Günter Henze;Herbert Jürgens

  • The MLL recombinome of acute leukemias.

    C. Meyer;B. Schneider;S. Jakob;S. Strehl

Frequent Co-Authors

Peter Bader
Peter Bader Goethe University Frankfurt
Peter Lang
Peter Lang University of Bern
Rupert Handgretinger
Rupert Handgretinger University of Tübingen
Ulrike Koehl
Ulrike Koehl Leipzig University
Halvard Bonig
Halvard Bonig Goethe University Frankfurt
Thomas Lehrnbecher
Thomas Lehrnbecher Goethe University Frankfurt
Martin Schrappe
Martin Schrappe Kiel University
Dietrich Niethammer
Dietrich Niethammer University of Tübingen
Arndt Borkhardt
Arndt Borkhardt Heinrich Heine University Düsseldorf
Simone Fulda
Simone Fulda Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare careers or need flexible learning options, several online degree programs and career pathways complement medical studies in the USA. Many students begin by becoming a registered nurse with an associate degree in nursing through online adn programs that offer accessible admissions and convenient coursework.

For registered nurses seeking career advancement, there are cheap rn to bsn online programs designed to be affordable and to fit within a working nurse’s busy schedule. These bridge programs can lead to higher earning potential and new opportunities in specialized areas of care.

Individuals from non-nursing backgrounds may consider pursuing nursing directly through direct entry online msn programs. These accelerated pathways are ideal for motivated career changers who want to quickly transition into advanced nursing roles.

If your interest is in healthcare administration or support roles, you might ask, can you get financial aid for medical billing and coding? Accredited online programs in medical billing and coding often have financial assistance, making training for this in-demand field more accessible.

Best Scientists Citing Thomas Klingebiel

Trending Scientists

Recently Published Articles